Hologic is submitting this report in accordance with 21.Cfr part 803.The submission is based upon the currently available information.The submission of this report does not represent a confirmation of device malfunction involving the hologic products in the event described.A device history record (dhr) review was conducted for the reported lot/serial number.The device was released meeting all qa specifications.The device involved in this event was not returned for evaluation purposes therefore visual and functional analysis of the product could not be performed.We are unable to confirm a relationship between the device and the issue reported.The information obtained during complaint investigation will be included in our global complaint trending and product surveillance will continue to monitor complaints of this type for adverse trends.If the product is received or additional information is obtained, the investigation will be reopened accordingly per standard operating procedure.
Event or Problem Description
It was reported that a patient received a biozorb device on (b)(6) 2018, during a lumpectomy.The patient, on the course from (b)(6) 2018, to (b)(6) 2018, required multiple visits to the surgeon's office due to seroma and infection which required drainage, aspiration cultures and medication.The patient received different antibiotics and one of the cultures was positive for mrsa.On (b)(6) 2018, the wound was reported as healing.No other information is available.